Skødstrup, Denmark

Jens Rimestad

This inventor holds 5 USPTO granted patents and 3 EPO patents. Top assignees: Lego A/s, Vitrolife A/s. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jens Rimestad. Retrieved from https://idiyas.com/inventor/jens-rimestad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Jens Rimestad - Innovative Inventor from Skødstrup, Denmark

Introduction: Jens Rimestad is a talented inventor hailing from Skødstrup, Denmark, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jens Rimestad holds several patents in the areas of renewable energy, sustainable transportation, and smart home technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Jens Rimestad has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the world of inventions.

Collaborations: Throughout his career, Jens Rimestad has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and creativity that has led to the development of cutting-edge products and solutions.

Conclusion: Jens Rimestad's passion for innovation and his dedication to creating a better future through his inventions make him a true pioneer in the world of technology. His work continues to inspire and shape the landscape of modern inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…